We are live on ! Find out more
MDCO

Medicines Co
MDCO

Delisted

MDCO was delisted on the 3rd of January, 2020.

Back to rankings

220 hedge funds and large institutions have $4.52B invested in Medicines Co in 2017 Q1 according to their latest regulatory filings, with 52 funds opening new positions, 87 increasing their positions, 62 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

136% more first-time investments, than exits

New positions opened: 52 | Existing positions closed: 22

75% more funds holding in top 10

Funds holding in top 10: 8 → 14 (+6)

62% more capital invested

Capital invested by funds: $2.79B → $4.52B (+$1.73B)

40% more repeat investments, than reductions

Existing positions increased: 87 | Existing positions reduced: 62

31% more call options, than puts

Call options by funds: $101M | Put options by funds: $77.5M

13% more funds holding

Funds holding: 195 → 220 (+25)

Holders
220
Holders Change
+25
Holders Change %
+12.82%
% of All Funds
5.48%
Holding in Top 10
14
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+75%
% of All Funds
0.35%
New
52
Increased
87
Reduced
62
Closed
22
Calls
$101M
Puts
$77.5M
Net Calls
+$23.7M
Net Calls Change
+$23.8M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$442M
2
AH
Aviva Holdings
Bahamas
+$175M
3
IAM
Iridian Asset Management
Connecticut
+$94.6M
4
Goldman Sachs
Goldman Sachs
New York
+$62.2M
5
TBC
Three Bays Capital
Massachusetts
+$62.2M

Top Sellers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
-$39.5M
2
Wells Fargo
Wells Fargo
California
-$36.3M
3
TCM
Tekla Capital Management
Massachusetts
-$26.2M
4
UBS AM
UBS AM
Illinois
-$21.4M
5
Invesco
Invesco
Georgia
-$20.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$42.7M +$1.08M +23,571 +3%
Bank of America
27
Bank of America
North Carolina
$42.6M +$2M +43,845 +5%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$42.5M +$2.52M +55,303 +7%
AA
29
Antipodean Advisors
New York
$40.6M +$27.3M +598,000 +257%
ECP
30
Elk Creek Partners
Colorado
$39.1M +$8.35M +183,131 +30%
EAM
31
Eagle Asset Management
Florida
$38.4M -$156K -3,423 -0.4%
RSCM
32
Rock Springs Capital Management
Maryland
$34.2M +$22.8K +500 +0.1%
SPC
33
Slate Path Capital
New York
$33.3M +$31M +680,000 New
O
34
OppenheimerFunds
New York
$30.1M -$33.2K -729 -0.1%
JP Morgan Chase
35
JP Morgan Chase
New York
$30M -$16.1M -353,400 -37%
Geode Capital Management
36
Geode Capital Management
Massachusetts
$29.7M +$2.15M +47,109 +8%
Macquarie Group
37
Macquarie Group
Australia
$29.6M +$242K +5,296 +0.9%
FCM
38
Frontier Capital Management
Massachusetts
$29.5M +$16.1M +352,230 +140%
RI
39
RTW Investments
New York
$28M +$9.05M +198,426 +53%
Principal Financial Group
40
Principal Financial Group
Iowa
$27.1M +$1.47M +32,301 +6%
PAM
41
Panagora Asset Management
Massachusetts
$24.4M +$1.16M +25,401 +5%
Norges Bank
42
Norges Bank
Norway
$23.4M -$8.56M -187,596 -28%
Ameriprise
43
Ameriprise
Minnesota
$21.6M +$4.04M +88,542 +25%
TA
44
Teachers Advisors
New York
$19.2M +$175K +3,834 +1%
Charles Schwab
45
Charles Schwab
California
$14.4M +$30.9K +678 +0.2%
ACM
46
Ashford Capital Management
Delaware
$14.3M -$3.68M -80,670 -22%
HS
47
HighVista Strategies
Massachusetts
$13.1M – – –
IHM
48
Iguana Healthcare Management
New York
$12.2M -$1.14M -25,000 -9%
BC
49
Broadfin Capital
New York
$10.5M -$10.1M -221,323 -51%
Westfield Capital Management
50
Westfield Capital Management
Massachusetts
$9.49M +$8.85M +194,000 New
1
2
3 4 5

MDCO Hedge Fund Activity: Q1 2017 in Review

220 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Medicines Co (MDCO) for Q1 2017, worth a combined $4.52B — up 62% from $2.79B a quarter earlier.

Buyers outnumbered sellers: 52 funds opened new MDCO positions and 22 closed out — a net gain of 30 holders — while 87 added to existing stakes and 62 trimmed.

The largest buyer was BlackRock, adding an estimated $442M. The largest seller was PFM Health Sciences, cutting an estimated $39.5M.

  • 220 institutional investors held Medicines Co (MDCO) as of Q1 2017, up from 195 in Q4 2016.
  • Funds reported $4.52B of Medicines Co stock for Q1 2017, up 62% quarter-over-quarter.
  • 52 funds opened new Medicines Co positions in Q1 2017 and 22 closed out, a net change of +30 holders.
  • The largest Medicines Co buyer in Q1 2017 was BlackRock, an estimated $442M added.
  • The largest Medicines Co seller in Q1 2017 was PFM Health Sciences, an estimated $39.5M sold.

Based on aggregated 13F filings for Q1 2017.